Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease

This study was designed to explore the value of monitoring miR-92a in T2DM patients with coronary heart disease (CHD). 40 ACS patients with prior history of CHD and diabetes while the onset time of diabetes preceded that of CHD by more than 2 years were enrolled as the DACS group(diabetic ACS group). 40 ACS subjects who had had a definite diagnosis of CHD for more than 2 years with no history of T2DM were recuited as the CACS group(chronic CHD...